Literature DB >> 24331786

ALS and neuromuscular disease: in search of the Holy Grail.

Matthew C Kiernan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24331786     DOI: 10.1016/S1474-4422(13)70226-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

1.  Deciphering genetic interactions between ALS genes using C. elegans.

Authors:  Martine Therrien; J Alex Parker
Journal:  Worm       Date:  2014-05-08

Review 2.  Microglia centered pathogenesis in ALS: insights in cell interconnectivity.

Authors:  Dora Brites; Ana R Vaz
Journal:  Front Cell Neurosci       Date:  2014-05-22       Impact factor: 5.505

Review 3.  Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis.

Authors:  Piia Vehviläinen; Jari Koistinaho; Goldsteins Gundars
Journal:  Front Cell Neurosci       Date:  2014-05-09       Impact factor: 5.505

4.  Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation.

Authors:  Meena Kumari Kotni; Mingzhu Zhao; Dong-Qing Wei
Journal:  Orphanet J Rare Dis       Date:  2016-11-05       Impact factor: 4.123

5.  Automated longitudinal monitoring of in vivo protein aggregation in neurodegenerative disease C. elegans models.

Authors:  Matteo Cornaglia; Gopalan Krishnamani; Laurent Mouchiroud; Vincenzo Sorrentino; Thomas Lehnert; Johan Auwerx; Martin A M Gijs
Journal:  Mol Neurodegener       Date:  2016-02-09       Impact factor: 14.195

6.  Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS.

Authors:  Florian Krach; Ranjan Batra; Emily C Wheeler; Anthony Q Vu; Ruth Wang; Kasey Hutt; Stuart J Rabin; Michael W Baughn; Ryan T Libby; Sandra Diaz-Garcia; Jennifer Stauffer; Elaine Pirie; Shahram Saberi; Maria Rodriguez; Assael A Madrigal; Zacharias Kohl; Beate Winner; Gene W Yeo; John Ravits
Journal:  Acta Neuropathol       Date:  2018-06-07       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.